EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of talaporfin sodium photodynamic therapy as a salvage treatment for locally recurrent esophageal squamous cell carcinoma

Mamoru Tanaka, Makiko Sasaki, Hirotada Nishie, Yuki Kojima, Yasunari Sasaki, Taketo Suzuki, Shigeki Fukusada, Naomi Sugimura, Keiji Ozeki, Takaya Shimura, Eiji Kubota, Hiromi Kataoka

International Journal of Clinical Oncology · 2025-11 · 30 (11) · 2307-2315

DOI: 10.1007/s10147-025-02864-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 02.09.2025. Verfasst von Mamoru Tanaka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Nagoya, Aichi, Japan. mtanaka@med.nagoya-cu…. Hauptthemen laut MEDLINE: Salvage Therapy, Photochemotherapy, Esophageal Squamous Cell Carcinoma, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, The Nitto Foundation, Toyoaki Scholarship Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) presents significant treatment challenges, with chemoradiotherapy (CRT) leading to local recurrence in 30-40% of cases. Limitations of traditional salvage therapies have driven interest in photodynamic therapy with talaporfin sodium (TS-PDT), a minimally invasive treatment with reduced phototoxicity, which has been increasingly utilized since its approval in Japan. METHODS: This retrospective study at the Nagoya City University Hospital (May 2016-December 2023) assessed the efficacy of TS-PDT for esophageal cancer after CRT or radiotherapy in 29 patients who met specific inclusion criteria. The evaluated outcomes included adverse events, local complete response (L-CR), progression-free survival (PFS), and overall survival (OS). RESULTS: Among the patients (23 men and 6 women; median age, 72 years), TS-PDT achieved an L-CR rate of 81.5% per patient and 87.8% per lesion, with a higher success rate against T1b lesions. The median local PFS was 44.1 months, and OS had not yet been reached, with a 1-year survival rate of 91.9%. The adverse events included esophageal strictures and perforations. CONCLUSION: TS-PDT is a potentially effective salvage treatment for ESCC, offering efficient local control and favorable survival outcomes. Despite some adverse events, its reduced phototoxicity and versatility make it a viable option, particularly for elderly patients. Further multicenter trials are warranted to validate its role in esophageal cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvage TherapyPhotochemotherapyEsophageal Squamous Cell CarcinomaNeoplasm Recurrence, LocalEsophageal NeoplasmsPorphyrinsPhotosensitizing AgentsHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

ChemoradiotherapyEsophageal squamous cell carcinomaLocal recurrenceOverall survivalPhotodynamic therapyProgression-free survivalSalvage treatmentTalaporfin sodium

Substanzen

TalaporfinPorphyrinsPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Nagoya, Aichi, Japan. mtanaka@med.nagoya-cu.ac.jp.
  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Nagoya, Aichi, Japan.
  • Department of Gastroenterology, Nagoya City University Midori Municipal Hospital, Nagoya, Aichi, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • The Nitto Foundation
  • Toyoaki Scholarship Foundation
  • Bristol Myers Squibb Foundation

Zitieren

APA

Tanaka, M., Sasaki, M., Nishie, H., Kojima, Y., Sasaki, Y., Suzuki, T., Fukusada, S., Sugimura, N., Ozeki, K., Shimura, T., Kubota, E., & Kataoka, H. (2025). Efficacy and safety of talaporfin sodium photodynamic therapy as a salvage treatment for locally recurrent esophageal squamous cell carcinoma. International Journal of Clinical Oncology, 30(11), 2307-2315. https://doi.org/10.1007/s10147-025-02864-5

Vancouver

Tanaka M, Sasaki M, Nishie H, Kojima Y, Sasaki Y, Suzuki T, et al. Efficacy and safety of talaporfin sodium photodynamic therapy as a salvage treatment for locally recurrent esophageal squamous cell carcinoma. International Journal of Clinical Oncology. 2025;30(11):2307-2315. doi:10.1007/s10147-025-02864-5

BibTeX
@article{Tanaka2025,
  author = {Tanaka, Mamoru and Sasaki, Makiko and Nishie, Hirotada and Kojima, Yuki and Sasaki, Yasunari and Suzuki, Taketo and Fukusada, Shigeki and Sugimura, Naomi and Ozeki, Keiji and Shimura, Takaya and Kubota, Eiji and Kataoka, Hiromi},
  title = {Efficacy and safety of talaporfin sodium photodynamic therapy as a salvage treatment for locally recurrent esophageal squamous cell carcinoma},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  volume = {30},
  number = {11},
  pages = {2307--2315},
  doi = {10.1007/s10147-025-02864-5}
}
Kostenlos starten →